Clinical Study
Transcatheter Mitral Valve Repair in Surgical High-Risk Patients: Gender-Specific Acute and Long-Term Outcomes
Table 6
Univariate cox regression analysis for future rehospitalization for heart failure.
| Variable | Men HR (95% CI) | value | Women HR (95% CI) | value |
| Age | 0.99 (0.97–1.01) | 0.43 | 1.01 (0.98–1.03) | 0.70 | Body mass index | 1.00 (0.96–1.05) | 0.87 | 1.00 (0.95–1.06) | 0.87 | Hypertension | 0.62 (0.41–0.94) | 0.0226 | 1.69 (0.88–3.25) | 0.12 | Hypercholesterolemia | 1.10 (0.74–1.63) | 0.65 | 1.60 (0.96–2.67) | 0.07 | Diabetes mellitus | 1.07 (0.71–1.61) | 0.75 | 1.77 (0.99–3.15) | 0.053 | Nicotine abuse | 1.50 (0.92–2.45) | 0.11 | 0.98 (0.44–2.15) | 0.96 | Dilative cardiomyopathy | 1.21 (0.76–1.90) | 0.42 | 1.68 (0.98–2.87) | 0.06 | Ischemic cardiomyopathy | 1.07 (0.72–1.60) | 0.73 | 1.47 (0.85–2.54) | 0.17 | Coronary artery disease | 0.91 (0.57–1.45) | 0.70 | 1.06 (0.64–1.78) | 0.82 | Renal failure | 1.32 (0.88–1.98) | 0.18 | 0.75 (0.44–1.27) | 0.29 | Atrial fibrillation | 1.13 (0.75–1.71) | 0.56 | 1.03 (0.61–1.75) | 0.91 | MR severity 4 versus 3 | 0.90 (0.60–1.33) | 0.58 | 1.45 (0.87–2.43) | 0.15 | LV ejection fraction <30% | 1.89 (1.25–2.86) | 0.0025 | 1.13 (0.56–2.25) | 0.74 | NT-proBNP (log) | 1.29 (1.06–1.58) | 0.0115 | 1.20 (0.90–1.58) | 0.21 | Success rate | 0.46 (0.26–0.83) | 0.0103 | 0.87 (0.38–2.03) | 0.76 | Logistic EuroSCORE | 1.00 (1.00–1.00) | 0.78 | 1.02 (1.01–1.03) | 0.0055 | Peripheral artery disease | 1.08 (0.54–2.15) | 0.82 | 1.12 (0.45–2.80) | 0.81 |
|
|
LV = left ventricular; MR = mitral regurgitation; MV = mitral valve; NT-proBNP = N-terminal probrain natriuretic peptide; CI = confidence interval; HR = hazard ratio.
|